AzTrials
AzTrials

Asthma in ChildrenNCT06539312

Project ASTHMA - Aligning With Schools To Help Manage Asthma and Improve Outcomes

A study testing APP assessment and management of asthma in people with Asthma in Children and Directly Observed Therapy, run by State University of New York at Buffalo at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Children with asthma from communities that experience health inequities frequently do not receive guideline-based asthma care, and as a result, account for a disproportionate percentage of asthma exacerbations, emergency department visits, and hospitalizations. Read more about this study

Who is it for?
Ages 4 to 13 years
Conditions the study is for
Asthma in Children, Directly Observed Therapy
What is being tested?
APP assessment and management of asthma
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
1 siteUnited States
Study dates
27 Sep 2024to 30 Apr 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 13 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • uncontrolled asthma

Who cannot join

  • other chronic lung disease such as cystic fibrosis

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Lucy CY Holmes, MD, MPH contact

716-323-0034

LHolmes@upa.chob.edu

Deanna Hamilton, MSEd contact

716-323-0060

DeHamilton@upa.chob.edu

United States1 site, 1 recruiting
  • University at Buffalo, Department of Pediatrics

    Buffalo, New York, 14203

    Lucy Holmes, MD, MPH, 716-323-0034, LHolmes@upa.chob.edu

    Recruiting

Other trials in United States

About this study

Official title: Project ASTHMA - Aligning With Schools To Help Manage Asthma and Decrease Health Inequities

Children with asthma from communities that experience health inequities frequently do not receive guideline-based asthma care, and as a result, account for a disproportionate percentage of asthma exacerbations, emergency department visits, and hospitalizations. Project ASTHMA (Aligning with Schools To Help Manage Asthma) tests the effectiveness of school-based health centers as a delivery model to improve health outcomes by providing children with guideline-based asthma assessments and preventive medication management, directly observed therapy of their preventive medication to support adherence, and self-management support. If successful, this multicomponent intervention will represent a cost effective and sustainable model to reduce asthma morbidity in historically marginalized communities, and has the potential to impact communities throughout the United States where over 2,500 school-based health centers operate.

Being tested
APP assessment and management of asthma
Keywords
Asthma, Children, School-based health center, NIH Guideline-based care, Controller medication, Directly Observed Therapy
Medical subject headings
Directly Observed Therapy, Asthma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • APP assessment and management of asthmaOther

    Also called DOT of morning dose of controller medication

    APPs will be trained to follow NIH guidelines for assessment and management of asthma, and to apply their knowledge to the care of the students. Students will also receive DOT of the morning dose of their controller medication.

Study groups in NCT06539312
Study groupRoleWhat they receive
SBHC groupExperimentalNot described
Receives: Other: APP assessment and management of asthma
PCP groupNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Asthma exacerbations

    Number of asthma exacerbations requiring systemic steroids based on medical records

    Measured: from 1 month after enrollment to the end of the school year for 1 school year; to be assessed after the end of the school year.

Secondary outcomes (10)
  1. Daytime asthma symptoms

    Frequency of daytime asthma symptoms based on questionnaire minimum value: 0 days maximum value: 28 days Higher scores mean a worse outcome.

    Measured: to be assessed at baseline and 1-, 3-, 5- and 7-months after enrollment for 1 school year

  2. Nighttime asthma symptoms

    Frequency of nighttime asthma symptoms based on questionnaire minimum value: 0 nights maximum value: 28 nights Higher scores mean a worse outcome.

    Measured: to be assessed at baseline and 1-, 3-, 5- and 7-months after enrollment for 1 school year

  3. Spirometry - FEV1

    Forced Expiratory Volume in 1 second

    Measured: to be assessed at baseline and 1-, 3-, 5- and 7-months after enrollment for 1 school year

  4. Spirometry - FEV1/FVC ratio

    FEV1/Forced Vital Capacity ratio

    Measured: to be assessed at baseline and 1-, 3-, 5- and 7-months after enrollment for 1 school year

  5. ED visits

    Number of ED visits for asthma symptoms based on medical records

    Measured: from 1 month after enrollment to the end of the school year for 1 school year; to be assessed after the end of the school year.

  6. Urgent care visits

    Number of urgent care visits for asthma symptoms based on medical records

    Measured: from 1 month after enrollment to the end of the school year for 1 school year; to be assessed after the end of the school year.

  7. Hospitalizations

    Number of hospitalizations based on medical records

    Measured: from 1 month after enrollment to the end of the school year; to be assessed after the end of the school year.

  8. Quality of Life - caregiver

    Children's Health Survey for Asthma, American Academy of Pediatrics Higher scores mean a better outcome.

    Measured: to be assessed at baseline and at 7-month follow-up for 1 school year

  9. Activity Limitation

    Degree of activity limitation based on questionnaire Higher scores mean a worse outcome.

    Measured: to be assessed at baseline and 1-, 3-, 5- and 7-months after enrollment for 1 school year

  10. school absenteeism

    Number of missed school days based on school records

    Measured: from 1 month after enrollment to the end of the school year for 1 school year; to be assessed after the end of the school year.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Aug 2024
  2. Study start27 Sep 2024
  3. Primary completion30 Apr 2028 (estimated)
  4. Study completion30 Apr 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06539312
Sponsor's protocol ID
STUDY00007712
Other IDs
R01MD018384
Status last verified
Jun 2026
First submitted
31 Jul 2024
Last updated
25 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing APP assessment and management of asthma in people with Asthma in Children and Directly Observed Therapy, run by State University of New York at Buffalo at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 25 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Lucy CY Holmes, MD, MPH (716-323-0034, LHolmes@upa.chob.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Asthma exacerbations (time frame: from 1 month after enrollment to the end of the school year for 1 school year; to be assessed after the end of the school year.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in